Reviewed by PillSeek Editorial Team · Last updated
About This Medication
This medication is a Yellow Oval 20 mm, Extended release tablet with imprint "577;750". It contains Metformin hydrochloride 750 mg; of Metformin hydrochloride[metformin];. This belongs to the Biguanide pharmacologic class. It is manufactured by Actavis Pharma, Inc.. For details please contact your physician.
Basic Information
- Imprint
- 577;750
- Color
- Yellow
- Shape
- Oval
- Size
- 20 mm
Drug Information
- Strength
- Metformin hydrochloride 750 mg;
- Dosage Form
- Extended release tablet
- RxCUI
- 860981
Pharmaceutical Classification
- Pharmacologic Class
- Biguanide
Related Medications
Other drugs in the same class: Biguanide
- GLUCOPHAGEmetformin hydrochloride 1000 mg;WHITE • OVAL
- GLUCOPHAGEmetformin hydrochloride 500 mg;WHITE • ROUND
- GLUCOPHAGEmetformin hydrochloride 750 mg;RED • OVAL
- GLUCOPHAGEmetformin hydrochloride 850 mg;WHITE • ROUND
- GlumetzaMETFORMIN HYDROCHLORIDE 1000 mg;WHITE • OVAL
- GlumetzaMETFORMIN HYDROCHLORIDE 500 mg;BLUE • OVAL
- KOMBIGLYZEsaxagliptin hydrochloride 2.5 mg;metformin hydrochloride 1000 mg;YELLOW • OVAL
- KOMBIGLYZEsaxagliptin hydrochloride 5 mg;metformin hydrochloride 1000 mg;PINK • OVAL
- KOMBIGLYZEsaxagliptin hydrochloride 5 mg;metformin hydrochloride 500 mg;BROWN • OVAL
- metformin hydrochlorideMETFORMIN HYDROCHLORIDE 1000 mg;WHITE • OVAL
Ingredients
- Active Ingredients
- Metformin hydrochloride[metformin];
- Inactive Ingredients
- Hypromellose 2208 (15000 mpa.s);silicon dioxide;d&c yellow no. 10;magnesium stearate;
Additional Information
- Manufacturer
- Actavis Pharma, Inc.
- Status (Rx/OTC)
- Rx
- Brand Names
- Actoplus Met, Glucophage, Glumetza, Invokamet, Janumet, Jentadueto, Kazano, Kombiglyze, Riomet, Segluromet, Synjardy, Trijardy, Xigduo, Zituvimet
Browse Related Pills
⚠️ Important: This information is for educational purposes only. Do not use this tool for medical diagnosis or treatment decisions. Always consult your pharmacist or healthcare provider for questions about your medications. Read full medical disclaimer.